| Pamela B Laird, SLP | |
|
3867 Bayou Acres Dr, Bastrop, LA 71220-9232 | |
| (318) 283-2080 | |
| (318) 283-0606 |
| Full Name | Pamela B Laird |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3867 Bayou Acres Dr, Bastrop, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932204997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4519 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pamela B Laird, SLP 3867 Bayou Acres Dr, Bastrop, LA 71220-9232 Ph: (318) 283-2080 | Pamela B Laird, SLP 3867 Bayou Acres Dr, Bastrop, LA 71220-9232 Ph: (318) 283-2080 |
News Archive
The English National Health Service reduced post-operative deaths by 37.2% following the introduction of globally recognized surgical guidelines - paving the way for life-saving action in low- and middle-income countries, a new study reveals.
Oxygen and glucose are the food of our brain. If they are absent, such as during a stroke, nerve cells die. An international research team at Charité - Universitätsmedizin Berlin, Germany, and McMaster University, Canada, has discovered a novel mechanism to prevent this cell death. The results of the study have now been published in the journal Proceedings of the National Academy of Sciences of the USA.
Low-income families have a high awareness of healthy diets but can't afford good quality and nutritious food, new research shows.
Biodel Inc. announced today that the U.S. Food and Drug Administration has accepted for review the company's new drug application (NDA) seeking approval to market VIAject® for the treatment of diabetes. VIAject® is Biodel's proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs.
Romosozumab is a bone-forming monoclonal antibody used in women after menopause for the treatment of severe osteoporosis if there is a high risk of bone fractures.
› Verified 8 days ago
Mrs. Katelyn Victoria Freeland, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1607 Martin L King St S, Bastrop, LA 71220 Phone: 318-283-3489 | |
Brooklyn Rea, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14968 Sulphur Springs Rd, Bastrop, LA 71220 Phone: 318-669-1451 | |
Ms. Amy C Smith, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1607 Martin L King St S, Bastrop, LA 71220 Phone: 318-669-4182 | |
Drucilla F Pylant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1607 Martin L King St S, Bastrop, LA 71220 Phone: 318-283-1600 | |
Mrs. Morgan Watson Johnston, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5960 Leamon Baker Rd, Bastrop, LA 71220 Phone: 318-537-1784 | |
Mrs. Crystal M Mckoin, SPEECH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3867 Bayou Acres Dr, Bastrop, LA 71220 Phone: 318-283-2080 Fax: 318-283-0606 |